Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
SANUWAVE Health Submits Final Module of PMA Application for FDA Approval of dermaPACE to Treat Diabetic Foot Ulcers
Wed, 07/6/11 - 01:22 pm
Sanuwave
FDA
diabetes
NeuroMetrix Reports Successful Marketing Launch of NC-stat®|DPNCheck™ at the American Diabetes Association 71st Scientific Sessions
Wed, 07/6/11 - 01:11 pm
NeuroMetrix
marketing
diabetes
Astellas' patent sale gins $609M for new round of dealmaking
Fierce Biotech
Thu, 06/30/11 - 09:36 am
Astellas
patents
diabetes
OSI Pharmaceuticals
The Diabetes Trade: Why We Like Amylin
Seeking Alpha
Thu, 06/30/11 - 08:02 am
diabetes
Amylin
Good news, bad news from diabetes gathering
Fierce Pharma
Tue, 06/28/11 - 09:26 am
diabetes
Takeda
GSK
Merck
Eli Lilly
Novo Nordisk Likely to Profit From Worldwide Growth in Diabetic Treatments
Seeking Alpha
Tue, 06/28/11 - 08:42 am
diabetes
Novo Nordisk
Bristol-Myers, AstraZeneca Diabetes Drug Shows Bladder, Breast Cancer Risk
Bloomberg
Sun, 06/26/11 - 12:09 pm
Bristol-Myers Squibb
AstraZeneca
Dapagliflozin
diabetes
Positive Results for Investigational Compound Lyxumia (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions
Yahoo/PR NewsWire
Sat, 06/25/11 - 08:43 pm
Lyxumia
diabetes
Sanofi
Two-Year Data Comparing Cardiovascular Events with Linagliptin and the Sulfonylurea, Glimepiride, Presented as Late-Breaking Poster at ADA
Yahoo/PR NewsWire
Sat, 06/25/11 - 08:42 pm
linagliptin
sulfonylurea
glimepiride
diabetes
Boehringer Ingelheim
Eli Lilly
New Phase III Data and Pooled Analysis for Linagliptin Show Improved Blood Sugar Control in Adults With Type 2 Diabetes When Used Alone and With Metformin
Yahoo/PR NewsWire
Sat, 06/25/11 - 12:03 pm
linagliptin
Boehringer Ingelheim
Eli Lilly
diabetes
Halozyme's Ultrafast Insulin Demonstrates Reduced Variability of Insulin Absorption for Type 1 Diabetes Patients Using Insulin Pumps
Yahoo/PR NewsWire
Sat, 06/25/11 - 11:56 am
Halozyme
Aspart-PH20
Novolog
insulin pumps
diabetes
Analysis Finds Byetta Associated with Lower Likelihood of Heart Failure Compared with Other Diabetes Therapies: Results Presented at ADA 2011
Yahoo/PR NewsWire
Sat, 06/25/11 - 11:53 am
Byetta
Amylin
diabetes
Takeda's Actos, Glaxo's Avandia Raise Risk of Eye Disease
San Francisco Gate, CA
Sat, 06/25/11 - 11:22 am
Takeda
Actos
GSK
Avandia
macular edema
diabetes
Analysis Provides New Insights Into Use of Symlin in Patients With Type 1 Diabetes Using Insulin Pumps
Yahoo/PR NewsWire
Sat, 06/25/11 - 10:41 am
Symlin
insulin pumps
diabetes
Amylin
Studies Show No Increased Risk of Cardiac Events in Diabetes Patients Treated with Afrezza
Yahoo/BusinessWire
Sat, 06/25/11 - 10:39 am
Afrezza
MannKind
insulin
diabetes
ADA diabetes roundup: Is surgery the answer?
Fri, 06/24/11 - 11:18 pm
ADA
diabetes
surgery
Children with diabetes urge FDA to accelerate artificial pancreas research
Thu, 06/23/11 - 06:17 pm
children
diabetes
FDA
Diamyd ends late-stage study of diabetes-prevention drug
Fierce Biotech
Thu, 06/23/11 - 11:10 am
Diamyd Medical
diabetes
Bristol-Myers Diabetes Drug Draws Scrutiny After Avandia, Actos
Bloomberg
Thu, 06/23/11 - 09:12 am
Avandia
diabetes
Bristol-Myers Squibb
Actos
Takeda
AstraZeneca
Dapagliflozin
Diabetes device maker Insulet announces double offering
Wed, 06/22/11 - 10:11 pm
diabetes
offer
Pages
« first
‹ previous
…
89
90
91
92
93
94
95
96
97
…
next ›
last »